Skip to main content
Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Pathogenesis, therapeutic strategies and biomarker development based on “omics” analysis related to microglia in Alzheimer’s disease

Fig. 1

Schematic indicating application of microglial omics in AD. This schematic shows that omics approaches, including genomics, epigenomics, transcriptomics, proteomics, and metabolomics/lipidomics, can be used to delineate the underlying mechanisms of microglia in AD, which is helpful to develop new therapeutic strategies and identify biomarkers to monitor disease progression

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094